Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $243.71 -2.78%
EPS Growth %: -20.4%
Financial Fact:
Total revenues: 374.18M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -20.4%
Financial Fact:
Total revenues: 374.18M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Ryman Hospitality closes $1.38B Grande Lakes Orlando deal
- Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
